Abstract
BackgroundMyositis-specific antibodies in patients with inflammatory myopathies are known to be associated with various clinical manifestations, classifications and diagnosis. Among them, recently found anti-transcriptional intermediary factor 1 (TIF1) α, β,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have